Gene G. Kinney - Jul 27, 2022 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
President and CEO
Signature
/s/ Michael Malecek, as Attorney in Fact for Gene G. Kinney
Stock symbol
PRTA
Transactions as of
Jul 27, 2022
Transactions value $
-$9,622
Form type
4
Date filed
7/29/2022, 09:30 PM
Previous filing
Feb 25, 2022
Next filing
Aug 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTA Ordinary Shares, par value $0.01 per share Options Exercise $2.41K +376 +2.94% $6.41* 13.2K Jul 27, 2022 Direct
transaction PRTA Ordinary Shares, par value $0.01 per share Sale -$12K -376 -2.86% $32.00 12.8K Jul 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Options Exercise $0 -376 -0.38% $0.00 98.7K Jul 27, 2022 Ordinary Shares 376 $6.41 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.
F3 The Reporting Person holds options that give him the right to acquire an aggregate of 2,103,398 shares at exercises prices ranging from $6.41 to $32.45, of which 1,571,938 are currently exercisable, and 531,460 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award.